Skip to main content

Lexaria Bioscience Stock Forecast, Price & News

+0.27 (+4.33 %)
(As of 05/13/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume385,969 shs
Average Volume820,483 shs
Market Capitalization$33.18 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive LEXX News and Ratings via Email

Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.


See More Headlines

Industry, Sector and Symbol

Industry Metal mining
Current SymbolNASDAQ:LEXX
Phone250 765 6424
Year FoundedN/A

Sales & Book Value

Annual Sales$380,000.00
Book Value$0.83 per share


Net Income$-4,090,000.00
Net Margins-1,046.77%




Market Cap$33.18 million
Next Earnings Date7/14/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

Medical Sector

2028th out of 2,042 stocks

Metal Mining Industry

89th out of 89 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Lexaria Bioscience (NASDAQ:LEXX) Frequently Asked Questions

What stocks does MarketBeat like better than Lexaria Bioscience?

Wall Street analysts have given Lexaria Bioscience a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Lexaria Bioscience wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Lexaria Bioscience's next earnings date?

Lexaria Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, July 14th 2021.
View our earnings forecast for Lexaria Bioscience

How were Lexaria Bioscience's earnings last quarter?

Lexaria Bioscience Corp. (NASDAQ:LEXX) announced its quarterly earnings results on Wednesday, April, 14th. The company reported ($0.28) earnings per share (EPS) for the quarter. The firm had revenue of $0.19 million for the quarter. Lexaria Bioscience had a negative net margin of 1,046.77% and a negative trailing twelve-month return on equity of 157.62%.
View Lexaria Bioscience's earnings history

Who are Lexaria Bioscience's key executives?

Lexaria Bioscience's management team includes the following people:
  • Mr. Christopher A. Bunka, Chairman & CEO (Age 59, Pay $300.8k)
  • Mr. John M. Docherty, Pres & Director (Age 52, Pay $242.52k)
  • Mr. Allan Spissinger C.A., CPA, CFO, Corp. Sec. & Treasurer (Age 52, Pay $121.66k)
  • Vanessa Carle, Head of Legal
  • Dr. Philip Ainslie, Advisor & Consultant

Who are some of Lexaria Bioscience's key competitors?

What is Lexaria Bioscience's stock symbol?

Lexaria Bioscience trades on the NASDAQ under the ticker symbol "LEXX."

How do I buy shares of Lexaria Bioscience?

Shares of LEXX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lexaria Bioscience's stock price today?

One share of LEXX stock can currently be purchased for approximately $6.50.

How much money does Lexaria Bioscience make?

Lexaria Bioscience has a market capitalization of $33.18 million and generates $380,000.00 in revenue each year.

How many employees does Lexaria Bioscience have?

Lexaria Bioscience employs 4 workers across the globe.

What is Lexaria Bioscience's official website?

The official website for Lexaria Bioscience is

How can I contact Lexaria Bioscience?

The company can be reached via phone at 250 765 6424.

This page was last updated on 5/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.